PREZATIDE COPPER ACETATE
UNII A3LEI4P1NB

Substance Identification & Data

This profile provides standardized clinical and technical data for Prezatide Copper Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A3LEI4P1NB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 130120-57-9 and the RxNorm Concept ID (RxCUI) 1314596. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A3LEI4P1NB

CAS Registry Number

130120-57-9

RxNorm Concept ID

1314596

Detailed Substance Profile

Preferred Name

PREZATIDE COPPER ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

A3LEI4P1NB

The specific atomic composition represented as a molecular structure string.

InChIKey

2C14H24N6O4.2C2H3O2.Cu

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LUNQZVCDZKODKF-PFVVTREHSA-L

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171726

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

9876021

Unique identification number in the NCBI database of chemical substances.

INN ID

6955

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CC-72

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H](C(=O)N[C@H](C(=O)O)CCCCN)(Cc1nc[nH]c1)NC(=O)CN.C(=O)([O-])C.[Cu+2].[C@@H](C(=O)N[C@H](C(=O)O)CCCCN)(Cc1nc[nH]c1)NC(=O)CN.C(=O)([O-])C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Prezatide Copper Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.